Contusugene ladenovec
A replication-defective adenoviral-CMV vector that encodes a wild-type p53 gene. Contusugene ladenovec induces tumor cells that have been transfected with the vector to produce wild-type p53, a tumor suppressor gene that is deleted or mutated in a significant number of cancers. In transfected tumor cells, the wild-type p-53 gene product exerts an antitumor effect by blocking cell cycle progression at the G1/S regulation point, activating DNA repair proteins in the presence of DNA damage, and initiating apoptosis when DNA damage is irreparable. (NCI04) [ ]
Term info
Contusugene ladenovec
- Ad-p53
- Ad5CMV p53 Gene
- Ad5CMV-p53 Gene
- Adeno-p53
- Adenovirus p53
- Advexin
- Contusugene ladenovec
- INGN 201
- INGN-201
- INGN201
- RPR/INGN-201
- p53 Gene, Ad5CMV
NCIT_C116978, NCIT_C128784, NCIT_C116977
600735-73-7
CTRP
Contusugene ladenovec
Ad5CMV-p53_Gene
683550
43016
Contusugene ladenovec
Pharmacologic Substance, Virus
C1135129
C2471
Term relations
- Antineoplastic Biological Agent
- Gene Therapy Agent
- Gene Transfer or Gene Delivery Agent
- Chemical_Or_Drug_Has_Physiologic_Effect some Negative Regulation of G1 to S Transition
- Chemical_Or_Drug_Has_Physiologic_Effect some Positive Regulation of Apoptosis
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some DNA Repair
- Chemical_Or_Drug_Has_Physiologic_Effect some Transcriptional Activation